Immunization of Mice with Lentiviral Vectors Targeted to MHC Class II+ Cells Is Due to Preferential Transduction of Dendritic Cells In Vivo

• Séverine Ciré,

  Affiliations Inserm, U 951, Molecular Immunology and Innovative Biotherapies, Genethon, Evry, France, UMR_S951, University of Evry, Genethon, Evry, France, Genethon, Evry, France

  ⨯
• Sylvie Da Rocha,

  Affiliations Inserm, U 951, Molecular Immunology and Innovative Biotherapies, Genethon, Evry, France, UMR_S951, University of Evry, Genethon, Evry, France, Genethon, Evry, France

  ⨯
• Roseline Yao,

  Affiliations Inserm, U 951, Molecular Immunology and Innovative Biotherapies, Genethon, Evry, France, UMR_S951, University of Evry, Genethon, Evry, France, Genethon, Evry, France

  ⨯
• Sylvain Fisson,

  Affiliations Inserm, U 951, Molecular Immunology and Innovative Biotherapies, Genethon, Evry, France, UMR_S951, University of Evry, Genethon, Evry, France, Genethon, Evry, France

  ⨯
• Christian J. Buchholz,

  Affiliation Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany

  ⨯
• Mary K. Collins,

  Affiliation Infection and Immunity, University College London, London, United Kingdom

  ⨯
• Anne Galy

  * E-mail: galy@genethon.fr

  Affiliations Inserm, U 951, Molecular Immunology and Innovative Biotherapies, Genethon, Evry, France, UMR_S951, University of Evry, Genethon, Evry, France, Genethon, Evry, France

  ⨯